SEC Company Response from Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Jan 29, 2016
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Jan. 29, 2016 · CIK: 0001585608 · Accession: 0001104659-16-092501
AI Filing Summary & Sentiment
File numbers found in text: 333-208905
Show Raw Text
CORRESP 1 filename1.htm January 29, 2016 Via Email and EDGAR Suzanne Hayes Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Jaguar Animal Health, Inc. – Withdrawal of Request for Acceleration Registration Statement on Form S-1 File No. 333-208905 Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on January 26, 2016, in which we requested the acceleration of the effective date of the above-referenced Registration Statement for Thursday, January 28, 2016, at 5:00 p.m., Eastern Standard Time, in accordance with Rule 461 promulgated under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date. Very truly yours, Jaguar Animal Health, Inc. /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer and President Jaguar Animal Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105 Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · www.jaguaranimalhealth.com